- Home
- SQNS vs VRCA Comparison
SQNS vs VRCA Comparison
Compare SQNS & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SQNS | VRCA |
|---|---|---|
| Founded | 2003 | 2013 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.3M | 32.7M |
| IPO Year | 2011 | 2018 |
Fundamental Metrics
Financial Performance| Metric | SQNS | VRCA |
|---|---|---|
| Price | $5.94 | $8.00 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 2 |
| Target Price | ★ $21.33 | N/A |
| AVG Volume (30 Days) | 193.4K | ★ 399.9K |
| Earning Date | 11-04-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $31,534,000.00 | $30,829,000.00 |
| Revenue This Year | N/A | $373.65 |
| Revenue Next Year | $70.05 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 3.20 | ★ 234.73 |
| 52 Week Low | $5.02 | $3.28 |
| 52 Week High | $58.30 | $9.82 |
Technical Indicators
Market Signals| Indicator | SQNS | VRCA |
|---|---|---|
| Relative Strength Index (RSI) | 44.78 | 62.44 |
| Support Level | $6.17 | $7.82 |
| Resistance Level | $6.98 | $9.78 |
| Average True Range (ATR) | 0.44 | 1.18 |
| MACD | 0.08 | 0.10 |
| Stochastic Oscillator | 36.02 | 64.93 |
Price Performance
Historical ComparisonAbout SQNS Sequans Communications S.A.
Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its offer 5G/4G chips and modules fully optimized for non-smartphone devices. The company covers applications such as smart mobility and logistics, smart utility meters, smart cities, smart industries, e-health and wellness, and smart homes to name few. The Company has one operating segment, which is the design and marketing of semiconductor components for cellular wireless systems. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.